These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9001979)

  • 21. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma.
    Massi D; Tarantini F; Franchi A; Paglierani M; Di Serio C; Pellerito S; Leoncini G; Cirino G; Geppetti P; Santucci M
    Mod Pathol; 2006 Feb; 19(2):246-54. PubMed ID: 16341148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
    Giehl KA; Nägele U; Volkenandt M; Berking C
    J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi.
    Niedojadło K; Łabedzka K; Łada E; Milewska A; Chwirot BW
    Pigment Cell Res; 2006 Feb; 19(1):43-50. PubMed ID: 16420245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions.
    Prieto VG; McNutt NS; Lugo J; Reed JA
    J Cutan Pathol; 1997 Mar; 24(3):145-50. PubMed ID: 9085149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
    Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.
    Wessel C; Westhoff CC; Nowak K; Moll I; Barth PJ
    Virchows Arch; 2008 Nov; 453(5):485-9. PubMed ID: 18813945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.
    Reed JA; McNutt NS; Prieto VG; Albino AP
    Am J Pathol; 1994 Jul; 145(1):97-104. PubMed ID: 8030760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors.
    Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P
    J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
    Pisacane AM; Risio M
    Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of basic fibroblast growth factor mRNA in melanocytic lesions by in situ hybridization.
    Scott G; Stoler M; Sarkar S; Halaban R
    J Invest Dermatol; 1991 Mar; 96(3):318-22. PubMed ID: 2002252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased mast cell density in invasive melanoma.
    Duncan LM; Richards LA; Mihm MC
    J Cutan Pathol; 1998 Jan; 25(1):11-5. PubMed ID: 9508338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression Pattern of Aquaporin 1 and Aquaporin 3 in Melanocytic and Nonmelanocytic Skin Tumors.
    Osorio G; Zulueta-Dorado T; González-Rodríguez P; Bernabéu-Wittel J; Conejo-Mir J; Ramírez-Lorca R; Echevarría M
    Am J Clin Pathol; 2019 Sep; 152(4):446-457. PubMed ID: 31305898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry.
    Sparrow LE; Eldon MJ; English DR; Heenan PJ
    Am J Dermatopathol; 1998 Jun; 20(3):255-61. PubMed ID: 9650698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma.
    Kim J; Dabiri S; Seeley ES
    PLoS One; 2011; 6(11):e27410. PubMed ID: 22096570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi.
    Florell SR; Bowen AR; Hanks AN; Murphy KJ; Grossman D
    J Cutan Pathol; 2005 Jan; 32(1):45-9. PubMed ID: 15660660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.